Sales Growth
Sales were $1,767 million, up 2% year-over-year and 10% on a quarterly basis, demonstrating solid strategic execution.
Specialties-Driven Revenue Increase
Specialties-driven sales of $1,412 million were up 3% year-over-year and 15% on a quarterly basis.
EBITDA Improvement
Consolidated adjusted EBITDA was $359 million, while specialties-driven EBITDA of $262 million was up 7% year-over-year and 4% quarterly.
Industrial Products Performance
Sales of $344 million were up 3% year-over-year, with EBITDA up 6% and margin improving to 22%, driven by higher volumes.
Potash Division Volume Increase
Potash sales volumes of 1,103,000 metric tons increased by about 20,000 tons year-over-year, mainly to Brazil and China.
Growing Solutions Division Growth
Sales of $495 million were up 3% year-over-year, while EBITDA increased 9%, driven by strategic execution and regional acquisitions.
Acquisition Strategy
Recent acquisition of Lavie Bio to advance the goal of becoming a global powerhouse in ag biologicals.